aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Mariana Oncology is a next-generation radiopharmaceutical company focused on developing treatments for solid tumors. By integrating expertise in ligand discovery, radiochemistry, radiobiology, and oncology research, the company aims to build a robust pipeline of innovative therapies. Their mission is to advance the field of radiopharmaceuticals to improve outcomes for cancer patients.
Mariana Oncology has made significant strides in the radiopharmaceutical industry, contributing to advancements in cancer treatment. The company collaborates with leading experts to push the boundaries of current oncology therapies, aiming for impactful clinical results.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Radiopharmaceuticals
Technology
Biotech
Tags
Healthtech
Model Types
Data Information, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Healthcare
Geographic Exposure
Global
When was Mariana Oncology founded?
Mariana Oncology was founded in 2021.
Where is Mariana Oncology's headquarters located?
Mariana Oncology's headquarters is located in Boston, MA, US.
When was Mariana Oncology's last funding round?
Mariana Oncology's most recent funding round was for $175M (USD) in September 2023.
How many employees does Mariana Oncology have?
Mariana Oncology has 32 employees as of Feb 4, 2024.
How much has Mariana Oncology raised to-date?
As of July 05, 2023, Mariana Oncology has raised a total of $250M (USD) since Sep 7, 2023.
Add Comparison
Total Raised to Date
$250M
USD
Last Update Sep 7, 2023
Last Deal Details
$175M
USD
Sep 7, 2023
Series B
Total Employees Over Time
32
As of Feb 2024
Mariana Oncology Address
Boston,
Massachusetts
02134
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts